AzTrials
AzTrials

StrokeIPACSSNCT03167346

The Investigation of Public Awareness of Core Stroke Symptoms

An observational study of Stroke and Awareness, run by Peking Union Medical College Hospital at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To investigate public awareness of core stroke symptoms in more than 40 years old population and its related factors. Read more about this study

Who is it for?
Ages 40 years and olderHealthy volunteers can take part
How many people
243,279 participants
Where
1 siteChina
Study dates
1 Jan 2017to 30 Jun 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Participants are more than 40 years old without specific requirements. This study is a population-based screening programme.

Who may be able to join

  • More than 40 years old (born before December 31st 1976) without specific requirements.
  • Be able to finish the questionnaire.

Who cannot join

  • Participants with disturbance of consciousness.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Department of Neurology,Peking Union Medical College Hospital,Shuaifuyuan 1,Dong Cheng District. Beijing

    Beijing, Beijing Municipality, 100730

Other trials in China

About this study

To investigate public awareness of core stroke symptoms in more than 40 years old population and its related factors.

Keywords
stroke, core symptoms, public awareness, FAST
Medical subject headings
Stroke, Behavior

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. awareness rate

    The awareness rate of core symptoms (FAST: facial droop, arm weakness, speech disturbance, time to call an ambulance)

    Measured: 2017-2017

Secondary outcomes (2)
  1. Associated factors

    The associated factors with the stroke recognition/ correct action to stroke

    Measured: 2017-2017

  2. Subgroup analysis

    Analysis of stroke recognition rate and correct action rate and their associated factor in subgroups.

    Measured: 2017-2020

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 May 2017
  2. Study start1 Jan 2017
  3. Primary completion31 May 2017
  4. Study completion30 Jun 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrolment
243,279 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03167346
Sponsor's protocol ID
PUMCH-IPACSS2017
Acronym
IPACSS
Status last verified
Oct 2021
First submitted
24 May 2017
Last updated
8 Oct 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Wolters FJ, Paul NL, Li L, Rothwell PM; Oxford Vascular Study. Sustained impact of UK FAST-test public education on response to stroke: a population-based time-series study. Int J Stroke. 2015 Oct;10(7):1108-14. doi: 10.1111/ijs.12484. Epub 2015 Apr 8.

    PubMed 25854424
  • Dombrowski SU, White M, Mackintosh JE, Gellert P, Araujo-Soares V, Thomson RG, Rodgers H, Ford GA, Sniehotta FF. The stroke 'Act FAST' campaign: remembered but not understood? Int J Stroke. 2015 Apr;10(3):324-30. doi: 10.1111/ijs.12353. Epub 2014 Aug 6.

    PubMed 25130981
  • Amano T, Yokota C, Sakamoto Y, Shigehatake Y, Inoue Y, Ishigami A, Hagihara T, Tomii Y, Miyashita F, Toyoda K, Minematsu K. Stroke education program of act FAST for junior high school students and their parents. J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):1040-5. doi: 10.1016/j.jstrokecerebrovasdis.2013.08.021. Epub 2013 Oct 2.

    PubMed 24094446
  • Jin H, Zhu S, Wei JW, Wang J, Liu M, Wu Y, Wong LK, Cheng Y, Xu E, Yang Q, Anderson CS, Huang Y; ChinaQUEST (Quality Evaluation of Stroke Care and Treatment) Investigators. Factors associated with prehospital delays in the presentation of acute stroke in urban China. Stroke. 2012 Feb;43(2):362-70. doi: 10.1161/STROKEAHA.111.623512. Epub 2012 Jan 12.

    PubMed 22246693
  • Zhao J, Liu R. Stroke 1-2-0: a rapid response programme for stroke in China. Lancet Neurol. 2017 Jan;16(1):27-28. doi: 10.1016/S1474-4422(16)30283-6. Epub 2016 Oct 28. No abstract available.

    PubMed 28029517
  • Longde W, Ling Y, Yang H, Yi Z, Yongjun W, Xunming J, Xiaoyuan N, Qiumin Q, Li H, Yuming X, Mei L, Jiayi S, Jing L, Dong Z. Fixed-dose combination treatment after stroke for secondary prevention in China: a national community-based study. Stroke. 2015 May;46(5):1295-300. doi: 10.1161/STROKEAHA.114.007384. Epub 2015 Mar 17.

    PubMed 25782466
  • Teuschl Y, Brainin M. Stroke education: discrepancies among factors influencing prehospital delay and stroke knowledge. Int J Stroke. 2010 Jun;5(3):187-208. doi: 10.1111/j.1747-4949.2010.00428.x.

    PubMed 20536616
  • Bouckaert M, Lemmens R, Thijs V. Reducing prehospital delay in acute stroke. Nat Rev Neurol. 2009 Sep;5(9):477-83. doi: 10.1038/nrneurol.2009.116. Epub 2009 Aug 11.

    PubMed 19668246
  • Fassbender K, Balucani C, Walter S, Levine SR, Haass A, Grotta J. Streamlining of prehospital stroke management: the golden hour. Lancet Neurol. 2013 Jun;12(6):585-96. doi: 10.1016/S1474-4422(13)70100-5.

    PubMed 23684084

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke and Awareness, run by Peking Union Medical College Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

awareness rate (time frame: 2017-2017). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03167346, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in